Key result
Combined kidney-pancreas transplantation linked to normalized LV metabolism and function versus kidney-only transplantation.
Why the study?
Heart failure drives mortality in diabetic uremia, where both conditions alter cardiac high-energy phosphates, but whether LV dysfunction is associated with abnormal high-energy phosphates and persists after kidney or kidney-pancreas transplantation remained unclear.
Does kidney or combined kidney-pancreas transplantation improve resting left ventricular energy metabolism in type 1 diabetic-uremic patients?
Cross-Sectional (n=67)
Does kidney or combined kidney-pancreas transplantation improve resting left ventricular energy metabolism in type 1 diabetic-uremic patients?
Combined kidney-pancreas transplantation appears to normalize resting left ventricular energy metabolism and function in type 1 diabetic-uremic patients, whereas kidney transplantation alone provides only partial improvement.
Answers are grounded in this paper and cite their sources.
Altered myocardial energetics may contribute to LV dysfunction in diabetic uremia; leaves open whether combined transplantation reverses these changes.
OBJECTIVES: To test whether left ventricular (LV) dysfunction affecting type 1 diabetic-uremic patients was associated with abnormal heart high-energy phosphates (HEPs) and to ascertain whether these alterations were also present in recipients of kidney or kidney-pancreas transplantation. BACKGROUND: Heart failure is the major determinant of mortality in patients with diabetic uremia. Both uremia and diabetes induce alterations of cardiac HEPs metabolism. METHODS: Magnetic resonance imaging and phosphorous magnetic resonance spectroscopy of the LV were performed in the resting state by means of a 1.5-T clinical scanner. Eleven diabetic-uremic patients, 5 nondiabetic patients with uremia, 11 diabetic recipients of kidney transplantation, and 16 diabetic recipients of combined kidney-pancreas transplantation were studied in a cross-sectional fashion. Eleven nondiabetic recipients of kidney-only transplant and 13 healthy subjects served as control groups. RESULTS: Uremic patients had higher LV mass, diastolic dysfunction, and lower phosphocreatine (PCr)/adenosine triphosphate (ATP) ratio in comparison with recipients of kidney-pancreas or nondiabetic recipients of kidney transplant. In diabetic recipients of kidney transplant the PCr/ATP ratio was higher than in uremic patients but was lower than in the controls. Recipients of combined kidney-pancreas transplant had a higher ratio than uremic patients but no difference was found in comparison with controls. CONCLUSIONS: Altered resting myocardial HEPs metabolism may contribute to LV dysfunction in diabetic-uremic patients. In diabetic recipients of kidney transplantation, a certain degree of LV metabolic and functional impairment was found. In combined kidney-pancreas recipients the resting LV metabolism and function were not different than in controls.
No takes yet. Share an insight, caveat, or question.
Perseghin et al. (2005) conducted a cross-sectional in Type 1 diabetic uremia (n=67). Kidney and kidney-pancreas transplantation vs. Uremic patients and healthy controls was evaluated on Resting left ventricular energy metabolism (PCr/ATP ratio) and LV dysfunction. Combined kidney-pancreas transplantation in diabetic-uremic patients was associated with normalized resting left ventricular metabolism and function, whereas kidney-only transplantation showed partial impairment.
Synapse has enriched 10 related papers. Consider them for comparative context: